Author Question: A client is to receive darbepoetin alfa (Aranesp) adjunctive medication during chemotherapy. The ... (Read 333 times)

natalie2426

  • Hero Member
  • *****
  • Posts: 524
A client is to receive darbepoetin alfa (Aranesp) adjunctive medication during chemotherapy. The client says, Not another drug. Why do I need this one? How should the nurse respond?
 
  1. I know you are tired of drugs, but this is just one more.
  2. This drug will help you grow red blood cells.
  3. This drug will help keep you from getting infections.
  4. This is an erythropoiesis-stimulating factor.
  5. This drug will help you get more oxygen around to your tissues so you feel better.

Question 2

A client has been treated with an erythropoiesis-stimulating factor. Which client assessment would the nurse interpret as indicating the goal of this treatment has been reached?
 
  1. The client's hemoglobin values have risen.
  2. The client reports less shortness of breath on exertion.
  3. The client has not had an episode of epistaxis in over three weeks.
  4. The client reports enjoying a walk with family for the first time in months.
  5. The client has not had a fever since treatment began.



pikon

  • Sr. Member
  • ****
  • Posts: 361
Answer to Question 1

Correct Answer: 2,5
Rationale 1: This response does not answer the client's question.
Rationale 2: Darbepoetin alfa (Aranesp) is an erythropoiesis-stimulating factor.
Rationale 3: Darbepoetin alfa (Aranesp) does not increase immunity.
Rationale 4: The nurse should explain the medication in terms the client can understand.
Rationale 5: Darbepoetin alfa (Aranesp) stimulates production of red blood cells which carry oxygen. Getting additional oxygen to the tissues helps the client feel better.

Answer to Question 2

Correct Answer: 1,2,4
Rationale 1: The purpose of this therapy is to increase red blood cells which would increase hemoglobin.
Rationale 2: Since the client has more RBCs, more oxygen can be carried to tissues.
Rationale 3: This drug supports RBC production, not platelet production.
Rationale 4: Increase in activity level indicates treatment success.
Rationale 5: This treatment supports red blood cell production, not white blood cell production.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Calcitonin is a naturally occurring hormone. In women who are at least 5 years beyond menopause, it slows bone loss and increases spinal bone density.

Did you know?

It is important to read food labels and choose foods with low cholesterol and saturated trans fat. You should limit saturated fat to no higher than 6% of daily calories.

Did you know?

No drugs are available to relieve parathyroid disease. Parathyroid disease is caused by a parathyroid tumor, and it needs to be removed by surgery.

Did you know?

More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

For a complete list of videos, visit our video library